Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 728 M727 M784 M827 M755 M795 M 3.16 B Research & development 394 M413 M416 M420 M421 M464 M 1.72 B Operating income 233 M444 M470 M431 M541 M599 M 2.04 B Non-Operating Income, Total 19 M21 M22 M21 M24 M0 67 M Interest expense, net of interest capitalized 18 M19 M22 M21 M21 M— — Non-Operating Income, excl. Interest Expenses 1 M2 M003 M0 3 M Unusual income/expense —————— — Pretax income 234 M456 M468 M445 M599 M593 M 2.1 B Equity in earnings —————— — Taxes 82 M143 M125 M129 M108 M101 M 463 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 152 M313 M343 M316 M491 M492 M 1.64 B Discontinued operations —————— — Net income 152 M313 M343 M316 M491 M492 M 1.64 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 152 M313 M343 M316 M491 M492 M 1.64 B Basic earnings per share (Basic EPS) 0.711.471.611.492.332.34 7.77 Diluted earnings per share (Diluted EPS) 0.71.461.61.472.322.33 7.72 Average basic shares outstanding 214 M213 M213 M213 M211 M210 M — Diluted shares outstanding 216 M215 M215 M215 M212 M211 M — EBITDA 243 M481 M508 M508 M553 M636 M 2.21 B EBIT 233 M444 M470 M431 M541 M599 M 2.04 B Cost of revenue 160 M159 M165 M166 M175 M176 M 682 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 10 M37 M38 M77 M12 M37 M 164 M